| Literature DB >> 32737389 |
Manuel Schultheiss1,2, Sebastian A Schober3, Marie Lodde4, Jannis Bodden4, Juliane Aichele4, Christina Müller-Leisse4, Bernhard Renger4, Franz Pfeiffer3,4, Daniela Pfeiffer4.
Abstract
Lung cancer is a major cause of death worldwide. As early detection can improve outcome, regular screening is of great interest, especially for certain risk groups. Besides low-dose computed tomography, chest X-ray is a potential option for screening. Convolutional network (CNN) based computer aided diagnosis systems have proven their ability of identifying nodules in radiographies and thus may assist radiologists in clinical practice. Based on segmented pulmonary nodules, we trained a CNN based one-stage detector (RetinaNet) with 257 annotated radiographs and 154 additional radiographs from a public dataset. We compared the performance of the convolutional network with the performance of two radiologists by conducting a reader study with 75 cases. Furthermore, the potential use for screening on patient level and the impact of foreign bodies with respect to false-positive detections was investigated. For nodule location detection, the architecture achieved a performance of 43 true-positives, 26 false-positives and 22 false-negatives. In comparison, performance of the two readers was 42 ± 2 true-positives, 28 ± 0 false-positives and 23 ± 2 false-negatives. For the screening task, we retrieved a ROC AUC value of 0.87 for the reader study test set. We found the trained RetinaNet architecture to be only slightly prone to foreign bodies in terms of misclassifications: out of 59 additional radiographs containing foreign bodies, false-positives in two radiographs were falsely detected due to foreign bodies.Entities:
Mesh:
Year: 2020 PMID: 32737389 PMCID: PMC7395787 DOI: 10.1038/s41598-020-69789-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Results for the nodule detection task for radiologists and the RetinaNet model. Evaluation was performed with respect to true-positives (TP), false-positives (FP) and false-negatives (FN).
| TP | FP | FN | |
|---|---|---|---|
| Radiologist A | 40 | 28 | 25 |
| Radiologist B | 44 | 28 | 21 |
| RetinaNet | 43 | 26 | 22 |
Figure 1Chest radiographies with nodules detected by RetinaNet. The ground-truth is marked in green and predictions are indicated by red rectangles. Predicted lung segmentation masks are marked in cyan color. (A) True-positive prediction (0.938) marked with a red rectangle by the CNN and an undetected, false-negative nodule in the left lung lobe. (B) True-positive prediction within the right lung lobe. (C) False-positive prediction outside of the chest.
Figure 2(A) Nodules per radiograph plotted against detection score with regression fit. (B) Nodule size plotted against detection score.
Figure 3(A) ROC curve for the screening task. The blue diagonal line marks cases with an equal prediction score for healthy and unhealthy cases. (B) FROC curve plotting the average sensitivities per radiograph against the average number of false positives per radiograph.
Number of radiographs with false-positive (FP) detections due to foreign bodies (FB) made by the RetinaNet architecture.
| Foreign body | Total radiographs | Radiographs with FP due to FB |
|---|---|---|
| Port | 26 | 1 |
| ECG | 21 | 1 |
| Sternum cerclage | 5 | 0 |
| Clips | 10 | 0 |
| Pacemaker | 3 | 0 |
False-positives due to FB only occurred for radiographs classified as port or ECG.
Figure 4Chest radiographies with foreign bodies wrongly detected as pulmonary nodules. (A) ECG device electrode detected as nodule (false-positive). (B) Port detected as nodule (false-positive). Overlapping boxes resemble multiple detected nodes within a small area (blue box).
Patient demographics for training and test subsets. Mass size is given as a fraction of the radiograph size (1.0 would indicate every pixel of the radiograph is a nodule). As for screening and foreign body (FB) test sets segmentations were unavailable, nodule mass and location were not provided. Within a radiograph multiple foreign bodies may occur. Secondary pathologies (SP) were excluded from the reader study. AM indicates acromastinum induced artifacts, which often show nodule-like morphological characteristics.
| Training | Test | ||
|---|---|---|---|
| Reader study | FB | ||
| Number | 257 | 75 | 59 |
| Age | 64 ± 13.43 | 55 ± 15.93 | 55 ± 17.41 |
| Left lobe | 420 | 32 | – |
| Right lobe | 435 | 33 | – |
| Mass size | 0.003 ± 0.009 | 0.004 ± 0.006 | – |
| Nodulous | 137 | 20 | – |
| Nodulous + SP | 30 | 0 | – |
| Nodulous + FB | 90 | 16 | 26 |
| Unsuspicious | – | 20 | – |
| Unsuspicious + SP | – | – | – |
| Unsuspicious + FB | – | 16 | 33 |
| Unsuspicious + AM | – | 3 | – |
| FB port | 46 | 7 | 26 |
| FB ECG | 6 | 4 | 21 |
| FB sternalcerclage | 4 | 1 | 5 |
| FB clips | 15 | 4 | 10 |
| FB pacemaker | 3 | 1 | 3 |
| FB other | 24 | 20 | 0 |
Figure 5General workflow for training and test phase.
Figure 6Utilized U-Net architecture for lung segmentation.